Nova Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVA LABS LTD, and what generic and branded alternatives to NOVA LABS LTD drugs are available?
NOVA LABS LTD has two approved drugs.
There is one tentative approval on NOVA LABS LTD drugs.
Drugs and US Patents for Nova Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nova Labs Ltd | PURIXAN | mercaptopurine | SUSPENSION;ORAL | 205919-001 | Apr 28, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Nova Labs Ltd | XROMI | hydroxyurea | SOLUTION;ORAL | 216593-001 | Apr 4, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Nova Labs Ltd | XROMI | hydroxyurea | SOLUTION;ORAL | 216593-001 | Apr 4, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.